EP. 1: Efficacy and Safety from the 72-Week Analysis of the HOPE Study
EP. 2: Clinical Implications and Evidence for the Treatment of Sickle Cell
EP. 3: Treatment Goals and Role of New Therapies for SCD
EP. 4: Voxelotor and Crizanlizumab: Safety and Tolerability
EP. 5: Managing Novel Therapy AEs in Sickle Cell Disease
